The Scientific Advisory Board supports the RESIST Management Board in questions of research strategy. The evaluation of the research projects is another task. This committee consists of the following leading national and international experts in the fields of infection and immunity.

Vorsitz: Prof. Maria Masucci

Research Group Molecular Mechanisms of Viral Oncogenesis, Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden

Prof. Charles M. Rice

Center for the Study of Hepatitis C, The Rockefeller University, New York, USA

Dr. Josef Lange

Hochschulrat der Medizinischen Hochschule Hannover

Prof. Eric G. Pamer

University of Chicago, Biological Sciences Division, director of the Duchossois Family Institute

Dr. Klaus Klumpp

Riboscience LLC und BioAge Labs, Kalifornien, USA

Prof. Erika von Mutius

Dr. von Haunersches Kinderspital, Ludwig-Maximilians-Universität München

Prof. Jean-Laurent Casanova

St. Giles Laboratory of Human Genetics of Infectious Diseases, The Rockefeller University, New York, USA

Prof. Peter Openshaw

Faculty of Medicine National Heart & Lung Institute, Imperial College London, UK

Prof. Andrew J. Macpherson

Klinik für Gastroenterologie, Universitätsklinik für Viszerale Chirurgie und Medizin, Inselspital, Bern, Schweiz

Prof. Luigi Daniele Notarangelo

National Institute of Allergy and Infectious Diseases (NIAID), Immune deficiency genetics diseases section, National Institutes of Health (NIH), Bethesda (Maryland), USA

Former members of the Scientific Advisory Board

Prof. Sandra Pellegrini

Institut Pasteur, Paris, France